Protocol of the Italian Radical Cystectomy Registry
1 other identifier
observational
1,000
1 country
1
Brief Summary
Background: Bladder cancer is the ninth most common type of cancer worldwide. In the past, Radical Cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy surgery. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy surgery comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24 months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence. Methods: The study is an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing Radical Cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with recruitment phase between 1st January 2017-31st June 2020). Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24 months after radical cystectomy surgery). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerves sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc). Discussion: The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 3, 2020
CompletedFirst Posted
Study publicly available on registry
January 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJanuary 14, 2020
January 1, 2020
3 years
January 3, 2020
January 11, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
Surgery time
Total surgery time, in minutes during surgery at baseline
Baseline
Type of urinary diversion
Type of urinary diversion performed during the cystectomy surgery at baseline
Baseline
Eventual conversion to open surgery
If the surgery technique changes from laproscopic surgery to open surgery during the intervention at baseline
Baseline
Amount of surgical blood loss
Amount of blood lost during the surgical procedure at baseline in milliliters
Baseline
Number of participants who underwent nerve-sparing
Nerve sparing during baseline surgery (no/unilateral/bilateral)
Baseline
Number of participants who underwent lymphadenectomy
lymphadenectomy (not performed/ bilateral external iliac nodes /bilateral presacral iliac) during baseline surgery
Baseline
Secondary Outcomes (5)
Histological evaluation of all patients
Immediately after surgery
Rate of Mortality
Up to 24 months
Rate of Hospitalization
Up to 24 months
Sexual potency rates
Up to 24 months
Continence rates
Up to 24 months
Study Arms (1)
Radical cystectomy
Patients with histologically confirmed diagnosis of bladder cancer undergoing radical cystectomy surgery at 28 Urology departments in Italy
Interventions
Procedure/Surgery: Radical cystectomy. Removal of urinary bladder with three different approaches: i) Robotic-assisted, ii) Laparoscopic, and iii) Open Surgery
Eligibility Criteria
Population is composed of subjects affected by bladder cancer that will undergo radical cystectomy. Surgery has been than divided in three different approaches: laparoscopic, robot-assisted and open.
You may qualify if:
- Male and female consecutively recruited patients
- Age ≥18 years
- Histologically confirmed diagnosis of bladder cancer eligible for radical cystectomy surgery (according to EAU guidelines) at date of enrollment
- Providing written, informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
policlinico Umberto I - Department of Gynecological-Obstetrics Sciences and Urological Sciences
Roma, 00161, Italy
Related Publications (1)
Porreca A, Palmer K, Artibani W, Antonelli A, Bianchi L, Brunocilla E, Bocciardi AM, Brausi M, Busetto GM, Carini M, Carrieri G, Celia A, Cindolo L, Cochetti G, Colombo R, De Berardinis E, De Cobelli O, Di Maida F, Ercolino A, Gaboardi F, Galfano A, Gallina A, Gallucci M, Introini C, Mearini E, Minervini A, Montorsi F, Musi G, Pini G, Schiavina R, Secco S, Serni S, Simeone C, Tasso G, D'Agostino D. Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer. BMC Cancer. 2021 Jan 11;21(1):51. doi: 10.1186/s12885-020-07748-7.
PMID: 33430820DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
January 3, 2020
First Posted
January 14, 2020
Study Start
January 1, 2017
Primary Completion
January 1, 2020
Study Completion
June 30, 2020
Last Updated
January 14, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share